Previous Article | Next Article 
Infection and Immunity, December 2001, p. 7517-7526, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7517-7526.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
WdChs2p, a Class I Chitin Synthase, Together with
WdChs3p (Class III) Contributes to Virulence in Wangiella
(Exophiala) dermatitidis
Zheng
Wang,1,
Li
Zheng,1,
Hongbo
Liu,1
Qingfeng
Wang,1
Melinda
Hauser,2
Sarah
Kauffman,2
Jeffery M.
Becker,2 and
Paul J.
Szaniszlo1,*
Section of Molecular Genetics and
Microbiology, School of Biological Science and Institute for Cellular
and Molecular Biology, The University of Texas at Austin, Austin, Texas
78712,1 and Microbiology Department,
University of Tennessee, Knoxville, Tennessee 379192
Received 21 June 2001/Returned for modification 13 July
2001/Accepted 13 September 2001
 |
ABSTRACT |
The chitin synthase structural gene WdCHS2 was isolated
by screening a subgenomic DNA library of Wangiella
dermatitidis by using a 0.6-kb PCR product of the gene as a
probe. The nucleotide sequence revealed a 2,784-bp open reading frame,
which encoded 928 amino acids, with a 59-bp intron near its 5' end.
Derived protein sequences showed highest amino acid identities with
those derived from the CiCHS1 gene of Coccidioides
immitis and the AnCHSC gene of Aspergillus
nidulans. The derived sequence also indicated that WdChs2p is an
orthologous enzyme of Chs1p of Saccharomyces cerevisiae,
which defines the class I chitin synthases. Disruptions of
WdCHS2 produced strains that showed no obvious
morphological defects in yeast vegetative growth or in ability to carry
out polymorphic transitions from yeast cells to hyphae or to isotropic forms. However, assays showed that membranes of wdchs2
mutants were drastically reduced in chitin synthase activity. Other
assays of membranes from a
wdchs1
wdchs3
wdchs4
triple
mutant showed that their residual chitin synthase activity was
extremely sensitive to trypsin activation and was responsible for the
majority of zymogenic activity. Although no loss of virulence was
detected when wdchs2
strains were tested in a mouse
model of acute infection, wdchs2
wdchs3
disruptants were considerably less virulent in the same model, even
though wdchs3
strains also had previously shown no loss
of virulence. This virulence attenuation in the wdchs2
wdchs3
mutants was similarly
documented in a limited fashion in more-sensitive
cyclophosphamide-induced immunocompromised mice. The importance of
WdChs2p and WdChs3p to the virulence of W. dermatitidis was
then confirmed by reconstituting virulence in the double mutant by the
reintroduction of either WdCHS2 or WdCHS3 into
the wdchs2
wdchs3
mutant background.
 |
INTRODUCTION |
Wangiella dermatitidis is
an asexual, dematiaceous (melanized) human pathogen that can cause
superficial, cutaneous, subcutaneous, and visceral or systemic
pheohyphomycosis (26). This fungus is also a valuable
model for discovering biologically and medically relevant information
about the more than 100 other dematiaceous agents of mycosis, due to
its vegetative polymorphism and ease of cultural manipulation
(16, 49). Furthermore, the haploid nature and rapidly
improving molecular genetic tractability of W. dermatitidis
allows efficient gene disruption and site-specific, integrative gene
expression studies (17, 26 27, 50, 51, 55, 56, 57, 58). At
the simplest level, polymorphism in W. dermatitidis is
expressed as three well-characterized modes of vegetative growth,
(e.g., blastic, apical, and isotropic), which are primarily associated
with the development of yeast, hyphal, and multicellular (sclerotic)
morphologies (15, 19, 56). Transitions among these
phenotypes in vitro are readily monitored and are easily induced in the
wild type by extreme acidity or by calcium or nitrogen limitation or,
in certain temperature-sensitive mutants, by the shift of cells to
37°C (19, 24, 47, 56). Collectively, these systems allow
detailed evaluations of gene disruption and gene overexpression effects
in all the growth forms of W. dermatitidis and make this
fungus extremely attractive for studies of cell wall-related virulence
factors at the molecular level (17).
Chitin, one of the major structural components of the fungal cell wall,
is produced by a variety of chitin synthases (Chsp) that are encoded by
a number of chitin synthase genes (CHS) (9, 20). These membrane-associated proteins are currently
distributed among three to six isozyme classes depending on the fungus
(4, 5, 33, 46). Chitin biosynthesis, chitin deposition
patterns, and the functions of the three Chsp of Saccharomyces
cerevisiae have been reviewed in great detail (6, 13,
38). Before bud emergence, Chs3p (class IV) lays down a chitin
ring through which a new bud will emerge (41, 43). Chitin
synthesis mediated by Chs2p (class II) then forms a primary septum
after the daughter cell nears complete development (43,
44). Finally, Chs1p (class I) acts as a repair enzyme at
cytokinesis, counterbalancing any chitin degradation caused by the
chitinase that augments cell separation (7, 10). Although
Chs1p contributes 90% of the chitin synthase activity when stimulated
by trypsin in vitro, it actually adds very little chitin to the cell
walls of yeast (37).
Genes encoding a class I chitin synthase have been identified in many
fungi other than S. cerevisiae, but studies of the
functional importance of their products have mainly involved
Candida albicans, Aspergillus nidulans, and
Aspergillus fumigatus (7, 12, 18, 21, 32, 35).
In these fungi, as in S. cerevisiae, the genes that encode
the class I isozymes are not essential and the functions of the class I
enzymes are not obvious, because with the exception of reduced chitin
synthase activities, mutants with these genes disrupted have no or only
very minor defects. In contrast, chs mutants of some fungi
with defective class III, IV, or V chitin synthases are reported to
have significantly altered growth (1, 23, 32, 53, 54). By
analogy with the roles played by the chitin synthases in S. cerevisiae, it is suspected that the chitin synthases of fungal
pathogens of humans should also play different roles in growth and
development and therefore should be important to their pathogenicity
and virulence. However, with the exception of results with one of the
two class III chitin synthases (AfChsGp) of A. fumigatus and
the class II chitin synthase (CaChs1p) of C. albicans, few
other published reports directly support this hypothesis (32,
36).
In W. dermatitidis, chitin is found primarily in the septal
regions in yeast cells, whereas in hyphal and isotopic forms it is also
localized throughout the cell wall (14, 22, 30). Previous
research with the chitin synthase inhibitor, polyoxin, strongly
suggests that chitin plays an important role in yeast-to-isotropic form
transitions (14) and may also play a role in
yeast-to-hypha transitions (30). Four different chitin
synthase structural genes (WdCHS), which encode class I, II,
III, and IV chitin synthases (WdChsp), were initially identified in
W. dermatitidis by cloning and sequencing PCR products,
prior to cloning and characterizing each full gene (5, 34, 48,
50, 51, 57). Very recently, evidence has also documented that
W. dermatitidis has a fifth WdCHS gene
(WdCHS5, class V), which encodes a protein with a myosin motor-like domain, as well as a chitin synthase domain
(27). These genes were then disrupted with the ultimate
aim of determining in a systematic way whether the chitin synthases of
this pathogen contribute to its virulence (26, 27, 50,
51). To date, the results document that no single WdChsp is
essential for viability and for yeast budding growth at 25°C and show
that only WdChs5p is required for viability at 37°C and therefore
virulence (27, 50, 51; unpublished data). These findings
suggested that one or more of some chitin synthases of W. dermatitidis were redundant for function with the products of
other WdCHS genes. Our finding that double mutants with both
WdCHS1 and WdCHS2 disrupted are incapable of
growth at 37°C but are capable of abnormal growth at 25°C strongly
supported this hypothesis and further suggested that the products of at
least these two genes were redundant for function at 25°C and also
for viability at 37°C (27, 50, 57; unpublished data).
These findings also strongly suggested that additional investigations
of these latter two genes and the relationship of their products with
those of WdCHS3 and WdCHS4 might help confirm this hypothesis.
In this report, we describe how WdCHS2, which encodes the
class I chitin synthase in W. dermatitidis, was cloned,
together with results about its characterization, expression, and
disruption in the wild-type strain and in a wdchs3
disruption mutant. We also estimate the relative levels of residual
enzymatic activities remaining in membranes of a number of single and
double chitin synthase mutants with either WdCHS2,
WdCHS3, or both disrupted and then compare these activities with
those of the wild type and of a
wdchs1
wdchs3
wdchs4
triple
mutant. In addition, we report that, although the disruption of
WdCHS2, like that of WdCHS3 (51),
did not affect virulence, the disruption of both WdCHS2 and
WdCHS3 in the same background caused a loss of virulence in mutants tested in two mouse models of acute infection. This
virulence loss was then restored by the reintroduction of either
WdCHS2 or WdCHS3 into the double-mutant
background. This is the first report that directly implicates a class I
chitin synthase with virulence among fungal pathogens of humans.
 |
MATERIALS AND METHODS |
Strains and media.
The W. dermatitidis strains
used in this work are listed in Table 1.
The wild-type strain 8656 (ATCC 34100 [Exophiala
dermatitidis CBS 525.76]), which has been extensively described
previously (see, for example, reference 24), was used as
the original parental stock for the derivation of all other strains.
Strains INV
F' (Invitrogen, San Diego, Calif.), JM109 (Promega,
Madison, Wis.), and XL1-Blue (Stratagene, La Jolla, Calif.) were used
as Escherichia coli plasmid hosts. W. dermatitidis cells were grown in the rich broth medium YPD
(50, 58) or the minimal medium SD (15). Drug
selection plates for isolating W. dermatitidis transformants were made by adding agar (1.5%) and hygromycin B (HmB; Sigma, St.
Louis, Mo.) or phleomycin (Sigma) to YPD at the final concentration of
50 µg/ml or chlorimuron ethyl (provided by J. Sweigard, DuPont Co.,
Wilmington, Del.) to SD for detection of resistance conferred by the
sulfonyl urea resistance (sur) gene at the final
concentration of 20 µg/ml. E. coli strains were grown in
Luria-Bertani medium supplemented with 100 µg of ampillicin or 20 µg of chloramphenicol per ml.
Plasmids and transformations.
The WdCHS2
replacement vector pLZ41 was constructed by using pLZ38, which contains
a 4.9-kb KpnI/XbaI fragment from the original WdCHS2 clone. After being cut with PstI, the
cohesive ends were blunted by fill in by using a Klenow fragment, and
the resulting fragment was cut by BamHI and then ligated
with the 2.9-kb BamHI/StuI fragment of pAN7-1
(39), which contains the promoter region of the
gpd gene and the hph gene for selection of
HmB-resistant transformants. The WdCHS2 integrative
disruption vector pLZ58 was constructed by using a 1.0-kb
EcoRI fragment of WdCHS2 from pLZ13 (this work)
that was inserted into the multiple cloning site of pCB1029 (provided
by J. Sweigard), which contains the sur gene marker
(50). The resulting plasmid pLZ52 was then used to produce
pLZ58 by digestion with XbaI, fill in with a Klenow fragment, digestion with SmaI, and then allowing self
ligation. The WdCHS1 gene disruption plasmid, pLZ56,
was constructed by cloning a 3.3-kb BglII fragment from
pUT737 containing the phleomycin resistance gene marker
(ble) into the BglII site of pWdCHS1.KS (34). The WdCHS4 disruption plasmid, pHY1-1,
was constructed by inserting the 0.8-kb
BclI/EcoRI fragment from pCHS4-5
(50) into pCB1029. These latter two disruption plasmids
were used sequentially to derive the triple mutant
wdchs1
wdchs3
wdchs4
. For
complementation of the
wdchs2
wdchs3
-E double mutant,
plasmids pZW9911 that contained WdCHS2 and pZW9912
that contained WdCHS3 were constructed by cloning a
5.8-kb XbaI fragment from pLZ14 (this work) and a 3.4-kb
KpnI-XbaI fragment from pZW122
(51) into the multiple cloning sites of pBF36, which is a
pBluescript KS(+) vector that also contained the ble marker.
Transformations of W. dermatitidis were performed by
electroporation of yeast cells as described previously
(50).
Preparation and analysis of DNA and construction of the partial
genomic library.
Genomic DNA was isolated from W. dermatitidis as previously described (50, 58).
Southern blotting was performed by standard methods (2).
DNA fragments (25 ng) used for probes in Southern analysis and colony
hybridizations were labeled with [
-32P]dATP
by using the Prime-a-Gene kit (Promega). To clone WdCHS2, a
partial genomic DNA library was constructed by completely digesting genomic DNA with XbaI and then excising and eluting the DNA
fragments that ranged from 5 to 7 kb from a gel after electrophoresis.
After ligation of the DNA into the pBluescript KS(+) vector that was cut by XbaI and dephosphorylated, the ligation product was
transformed into XL1-Blue competent cells. The resulting
XbaI library contained about 7,000 independent clones that
were divided into several small pools. One pool from about 1,400 independent colonies was shown to contain the WdCHS2 gene
fragment by PCR amplification and then subjected to library screening
by colony hybridization (2). Methods for nucleic acid
analysis have also been described (50, 58), except for the
analysis of the WdCHS2 promoter region, which was performed
with MatInspector (40).
Primers and RT-PCR amplifications.
The primers used to
detect expression and to confirm the putative intron in
WdCHS2 were CHS2.RT (5'-GACATGGCTACAACCGTCTA-3') and CHS2.GSP2 (5'-CTATGTAATCGTTTCTGCCGTAACC-3'). The
first strand of cDNA synthesis was performed according to the protocol
supplied with SuperScript II reverse transcriptase (Life Technologies, Inc., Rockville, Md.) by using 1 µg of mRNA isolated from wild-type cells grown at 25 or 37°C. The first strand synthesized was subject to PCR amplification. Amplification was for 35 cycles as follows: premelt, 94°C for 5 min; denaturation, 94°C for 1 min;
hybridization, 50°C for 2 min; and extension, 72°C for 3 min (10 min on the last cycle). The primers for the semiquantitative reverse
transcription-PCR (RT-PCR) were designed to ensure the exclusive
amplification of WdCHS2 by identifying a region of low
conservation (bases 1047 to 1462) in the gene after alignment of all
the known WdCHS sequences. The resulting specific primers
had the following sequences: CHS2F (5'-GCCTACGGTCAGCAGTATGGGCAGCAT-3') and CHS2R
(5'-GGAGGTTTCGCGTGAGGAACGTTGGC-3'). The RNA for the
semiquantitative evaluations of WdCHS2 expression was
obtained from 109 wild-type cells cultured in liquid YPD at
25 or 37°C. The inoculum used for these experimental cultures was
from yeast cultures grown at 25°C to mid-log phase through four
successive growth cycles, after which time the final subculture was
split into two equal parts for incubation at the two temperatures for
3 h prior to RNA extraction with acid phenol. After DNase
treatment (1 h) at 37°C, DNA-free RNA samples were dissolved and
diluted in RNase-free water and diluted to various concentrations.
Primer pairs for the 18S rRNA gene and for their 18S PCR
Competimers (Ambion, Inc., Austin, Tex.) were used to titrate
the two RNA samples to the same total RNA level. The actual RT-PCR for
each sample was then done with one tube by using the Access RT-PCR
System (Promega). The RT-PCR mixture for 25 µl consisted of 1 µl of
MgSO4 (25 mM), 0.5 µl of deoxynucleoside triphosphate (10 mM), 2.5 µl of buffer (10×), 1 µl of forward and reverse primers
(2.5 µM), 0.5 µl of avian myeloblastosis virus (AMV) reverse
transcriptase, 0.5 µl of Tfl DNA polymerase, 1 to 8 µl
of total RNA in proper dilution, and RNase-free water supplemented to
25 µl. The RT-PCR was run in a GeneAmp 2400 PCR system (Perkin-Elmer,
Wellesley, Mass.) with the following cycling conditions: 48°C for
1 h and 94°C for 2 min; followed by different cycles of 94°C
for 1 min, 58°C for 1 min, and 70°C for 1 min; and then an extra
step for elongation at 68°C for 5 min. Both the cycling number and
the template amount were carefully calibrated to ensure that the RT-PCR
was done within the exponential phase of amplification. For each
sample, a parallel negative control made up with the same components
used for normal RT-PCR except AMV reverse transcriptase was used to
ensure there was no trace DNA contamination. Products of the RT-PCR
were run on 1.2% agarose gels and then viewed under UV light and
analyzed by densitometry by using the AlphaImager 1220 Documentation
and Analysis system (Carnock, Staffordshire, United Kingdom).
Chitin content and chitin synthase activity assays.
Chitin
contents were measured by the procedure described previously (50,
58). Cell membranes were prepared and activities of chitin
synthase were determined by a modification of the method of Orlean
(37) as described previously (51, 58).
Virulence studies of mice.
Tests for virulence in an
immunocompetent mouse model system were done as described previously
(17, 50). Survival fractions were calculated by using the
Kaplan-Meier method, and survival curves were tested for significant
difference (P < 0.01) by the Mantel-Haenszel test with
GraphPad Prism software, version 3.00, for Windows. Tests for virulence
in an immunocompromised mouse model were carried out with mice injected
with cyclophosphamide at day 4, and one was done prior to fungal
infection. This treatment induces severe neutropenia resulting in a 10- to 100-fold-greater sensitivity in the mice to infectious fungi
(31, 42, 45). This is normally reflected in a 10- to
100-fold less infectious dose to produce a 50% lethal dose
(LD50) comparable to the LD50 with
immunocompetent mice. Because the usual inoculum of W. dermatitidis used in mice with functioning immune systems was
9 × 106 cells, this inoculum size and three other
smaller ones (3 × 106, 1 × 106, and
3.3 × 105) were used in these experiments, which
involved comparisons of only the wild-type strain and one
wdchs2
wdchs3
mutant.
Nucleotide sequence accession number.
The nucleotide
sequence of the WdCHS2 gene was assigned GenBank accession
number AF 052606.
 |
RESULTS |
WdCHS2 encodes a class I chitin synthase.
A partial genomic DNA library was screened by using a 0.6-kb PCR
fragment of WdCHS2 as a probe, and two clones were obtained. Restriction enzyme mapping showed that both (pLZ13 and pLZ14) contained
identical 5.6-kb inserts (see Fig. 3A), but with opposite orientations.
Several subclones were then used to sequence a 4.2-kb region on both
strands. The resulting sequence (Fig. 1)
revealed a 2,784-bp open reading frame with a 59-bp putative intron
sequence found between bp 20 and 78. The putative intron began with
GTAAAC, had the invariant CTGATT
sequence in the middle, and ended with TAG. Therefore, it
was similar to those reported for other eukaryotic introns
(3) and also matched the consensus of most introns found
in other genes of W. dermatitidis (the boldface nucleotides
are conserved in most introns identified to date in W. dermatitidis [11]). The predicted amino acid
sequence of WdChs2p derived from these nucleotide sequences was
928 amino acids, with a molecular mass of 106 kDa and a putative pI of
7.28. Comparisons of the deduced WdChs2p protein with other deduced chitin synthases indicated the highest amino acid identity with CiChs1p
(72%) of Coccidioides immitis (GenBank submission no. AF276826; M. Mandel, J. N. Galgiani, and M. J. Orbach).
Progressively lower amino acid identities were found with AnChsC (66%)
of A. nidulans (35), NcChs3p (62%) of N. crassa (GenBank submission no. AF127086; A. Beth-Din and O. Yarden), CaChs1p (44%) of C. albicans (12),
and Chs1p (44%) of S. cerevisiae (7). Thus, WdChs2p represents a class I chitin synthase as originally defined by
Bowen et al. (5) and then extended by others
(4, 46). Interestingly, analysis of the WdCHS2
5' upsteam sequence identified a number of sequences for putative
cis-acting elements for AbaAp and StrEp/BrlAp, which
is similar to the finding with AnCHSC of A. nidulans, where such elements have been identified and
suggested to be important in the transcriptional regulation of chitin
biosynthesis during sporulation (18). A number of other
stress-related and sporulation-related putative cis-acting
elements were also identified for StuAp and for Nit2p. These putative
regulatory elements have also been identified in the upstream regions
of WdCHS3 and WdCHS5 (unpublished data).

View larger version (101K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleotide and derived amino acid sequences of the
WdCHS2 gene of W. dermatitidis. The putative
intron sequence is indicated in lowercase. The conserved intron
splicing signals are underlined. The sequences corresponding to the
CHS primer 1 and primer 2 binding sites are also underlined.
The putative start site is at position 1.
|
|
Expression of WdCHS2 occurs at both 25 and 37°C.
Northern blot analyses of total RNA were not sensitive enough to detect
the expression of WdCHS2 (data not shown). Therefore, more-sensitive assays involving RT-PCR were carried out, first to
detect the expression of WdCHS genes and simultaneously to confirm the putative intron identified by sequencing WdCHS2
and then in an attempt to determine whether this gene, like
WdCHS3 (51), exhibits significant enhanced
expression in cells shifted from 25 to 37°C. For the former, the
RT-PCR amplifications were performed with primers that bind sequences
adjacent to the putative intron sequence. The results documented that
WdCH2 was expressed at both 25 and 37°C (Fig.
2). Furthermore, the RT-PCR product derived was determined to be about 300 bp in size (Fig. 2A and B, lanes
3), which was about 50 to 60 bp shorter than the product amplified from
the cloned WdCHS2 gene in pLZ13 (Fig. 2A and B, lanes 2).
Sequencing of this RT-PCR product showed that the intron of
WdCHS2 had been spliced from its mRNA (data not shown). For the latter, our more-sensitive, semiquantitative RT-PCR methodology confirmed that there was detectable expression of WdCHS2 at
both 25 and 37°C (Fig. 2C). This methodology also indicated that,
although WdCHS2 expression increased in cells shifted from
25 to 37°C (Fig. 2Ca), its estimated increase was only about 32%
when the bands were standardized against the RT-PCR products generated
with primers specific for 18S rRNA amplifications (Fig. 2Cb) and then
compared by densitometric analysis (data not shown).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
RT-PCR amplifications of WdCHS2 to confirm
the putative intron sequence and to document and semiquantitatively
estimate the levels of WdCHS2 gene expression at both 25 and
37°C. (A) The RT-PCR amplification was with mRNA isolated from
wild-type cells grown to mid-log phase at 25°C in YPD medium (lane 3)
and primers WdCHS2.RT and WdCHS2.GSP. A PCR amplification was also
performed as a control by using a genomic clone of WdCHS2 as
a temple (lane 2). The DNA standard (1-kb ladder) is in lane 1. (B)
Similar to the analysis shown in panel A except the RT-PCR
amplification was performed with mRNA isolated from wild-type cells
grown to mid-log phase at 37°C in YPD medium. (C) Total RNA samples
of 0.5 ng from 25°C (lane a1) and 37°C (lane a2) were reverse
transcribed and further amplified by PCR with primer CHS2F and CHS2R,
which were standardized against internal controls (lanes b1 and b2)
represented by RT-PCR products from the same RNA samples used in lanes
a1 and b1 but generated by using primers exclusive for the
amplification of the 18S rRNA gene.
|
|
WdCHS2 is not an essential gene, but WdChs2p produces
much of the chitin synthase zymogenic activity detected in vitro.
To study the function of WdChs2p in W. dermatitidis, a
WdCHS2 gene disruption was performed by a one-step gene
replacement method (Fig. 3B). Yeast cells
were transformed with the KpnI and XbaI fragment
released from pLZ41 at an efficiency of eight transformants/µg of DNA. Southern analysis of genomic DNA from 14 HmB-resistant transformants showed that 7 resulted from site-specific integrations and indicated that they were WdCHS2 disruption
(wdchs2
) strains (Fig. 3C; data shown only for
wdchs2
-1). However, neither growth rate
determinations (Fig. 4) nor microscopic
observations (data not shown) revealed that any of the
wdchs2
disruptants had observable defects in terms of
yeast vegetative growth at 25 or 37°C or of phenotype transition
potential during the formation of hyphae or isotropic forms from yeast
cells (data not shown). Chitin content and Calcofluor white staining
patterns indicative of chitin localization in
wdchs2
-1 cells were also identical to those of
the wild type (data not shown).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Disruption of WdCHS2 in W. dermatitidis and complementation of the
wdchs2 wdchs3 -E double mutant
with either WdCHS2 or WdCHS3. (A) Restriction
enzyme map of the 5.8-kb XbaI fragment containing the
WdCHS2 gene. The arrow indicates the position and length of
WdCHS2 in the insert and the direction of its transcription.
Abbreviations: B, BamHI; G, BglII;
HindIII; K, KpnI; P, PstI; S,
SalI; Sa, SacII. (B) The one-step gene disruption
strategy for generating the disruption strain
wdchs2 -1. The solid line indicates the
position of the PCR-generated probe used in the results shown in panel
C. (C) Southern blot analysis of the wild type (lane 1 and lane 7), the
single disruption strains wdchs2 -1 (lanes 2 and 8) and wdchs3 -1 (lanes 3 and 9), the
double disruption strain
wdchs2 wdchs3 -E (lanes 4 and 10),
and the complemented strains
wdchs2 wdchs3 -WdCHS2-E2-1 (lanes
5 and 11) and
wdchs2 wdchs3 -WdCHS3-E3-3 (lanes
6 and 12). Genomic DNA from each strain was digested with
XbaI and hybridized with a 417-bp PCR probe of
WdCHS2 (lanes 1 to 6) and a 3.2-kb
KpnI-XbaI fragment (lanes 7 to 12).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of growth rate at 25°C and 37°C of
W. dermatitidis 8656 (wild type [wt]) and selected
wdchs2 and wdchs3 single and double
mutants. Mid-log-phase yeast cells were used to inoculate YPD medium at
an initial concentration of about 105 cells/ml. Cultures
were incubated with shaking at 37°C in a Psycrotherm Incubator-Shaker
(New Brunswick Scientific Co., Edison, N.J.) or at 25°C in a New
Brunswick G-76 Water Bath Shaker at gyrotory speed settings of 200 rpm.
Optical densities were measured by using a DU Spectrophotometer
(Beckman Instruments, Inc., Irvine, Calif.).
|
|
It has been shown that Chs1p (class I) in S. cerevisiae
contributes most of the measurable zymogenic activity detected under standard assay conditions, even though it contributes little cell wall
chitin (8). To test whether this was also true for the WdChs2p (class I) isozyme of W. dermatitidis, chitin
synthase activity assays were performed with membrane preparations from the wild type and the wdchs2
-1 strain. The
results showed that the WdChsp activities of membranes pretreated with
trypsin (the so-called zymogenic activity) were reduced by about 85%
in membrane preparations of strain wdchs2
-1
compared to those of the wild-type strain (Fig.
5). This confirmed similar findings with
membrane preparations from this strain and others having
WdCHS2 disrupted with a hisG cassette, such as
the wdchs2
-3
(wdchs2::hisG) strain (58).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 5.
Comparisons of relative chitin synthase activities. The
wild-type strain (wt) and the wdchs2 -1,
wdchs3 -1,
wdchs2 wdchs3 -E,
wdchs2 wdchs3 -WdCHS2-E2-1,
wdchs2 wdchs3 -WdCHS3-E3-3,
and
wdchs1 wdchs3 wdchs4 -1
mutant strains were grown in YPD liquid medium at 37°C for 20 h
prior to membrane harvest. The membrane protein (30 µg) from each
strain was assayed after a 40-µg/ml trypsin treatment. The results
are derived from at least two independent experiments. Standard
deviations are shown.
|
|
WdChs2p is extremely sensitive to chitin synthase activation by
trypsin.
Because about 85% of chitin synthase activity in
membranes of cells grown at 37°C was estimated to result
from WdChs2p (Fig. 5) and because a quadruple mutant with
only WdChs2p has not been derived and WdChs5p seems to
contribute only minimally to total WdChsp activity (unpublished data),
the chitin synthase activity present in a
wdchs1
wdchs3
wdchs4
triple
mutant was measured. To derive this strain, the WdCHS1 gene
was disrupted in the wdchs3
-1 mutant by
transforming with an 8.5-kb StuI fragment from pLZ56 (57) by using a one-step replacement method. Of the
resulting phleomycin-resistant transformants, 5% were shown to be
wdchs1
wdchs3
double mutants by Southern
blotting (data not shown). The vector pHY1 was then linearized with
BstXI and used to disrupt WdCHS4 in the
wdchs1
wdchs3
double mutant. Among the
resulting sulfonyl urea-resistant transformants, 50% were confirmed by
Southern blotting to be
wdchs1
wdchs3
wdchs4
triple
mutants (data not shown). Surprisingly, this triple mutant grew well at
25 and 37°C and showed only a short yeast chain-clumpy phenotype
(data not shown), which is the combined phenotype of
wdchs1
(chains) and the wdchs4
(clumpy) single mutants (50, 57), and was as virulent as
the wild-type strain in our mouse model (see Fig. 7A). However,
unexpectedly low levels of WdChs2p activity were detected after
trypsin activation of membranes from the triple mutant grown at 37°C
(Fig. 5), when tested by using our standard concentration of trypsin
(40 µg/ml). Therefore, the WdChs2p activity was retested with
lower trypsin concentrations, as was done previously during
the characterization of the residual activity of a
wdchs1
wdchs2
wdchs3
mutant,
with only WdChs4p and WdChs5p (50). As was shown with that
mutant, the results showed that our standard concentration of trypsin was in excess of the concentration required for demonstrating maximal
activity of the residual membrane activity of the
wdchs1
wdchs3
wdchs4
mutant
(Fig. 6A). The results also substantiated
that the enzyme was indeed zymogenic. In addition, the results showed
that the residual activity in membranes of
wdchs1
wdchs3
wdchs4
could be
activated to 10 times higher activity than the residual membrane activity of the
wdchs1
wdchs2
wdchs3
mutant
(50) by trypsin concentrations as low as 1.5 µg/ml (Fig.
6A) in just 5 min (Fig. 6B).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 6.
Zymogenic characteristic of the residual activity in the
triple mutant
wdchs1 wdchs3 wdchs4 -1.
Membrane proteins were isolated from mutant cells grown in YPD liquid
medium at 37°C for 20 h. (A) Trypsin titration of 30 µg of
membrane proteins. (B) Optimal activation time of WdChs2p in the
presence of 1.5 µg of trypsin/ml. The results are derived from two
independent experiments, and each sample was duplicated. Standard
deviations are shown.
|
|
The wdchs2
wdchs3
double mutant, but
not the wdchs2
single mutant, is less virulent.
Because all of the single wdchs
mutants of W. dermatitidis, except those with newly discovered WdCHS5
disrupted, are as virulent as the wild type in animal tests (27,
50, 51; unpublished data), numerous combinations of double and
triple wdchs
mutants have been constructed and tested
similarly. Of those available and capable of growth at 37°C, which
includes the
wdchs1
wdchs3
wdchs4
-1 triple mutant but not those with WdCHS1 and
WdCHS2 disrupted in the same background, only the
wdchs2
wdchs3
double mutants constructed by
integrating the BamHI-linearized plasmid pLZ58 into the
WdCHS2 locus of wdchs3
-1 have so
far been found to be less virulent in our immunocompetent mouse
model (Fig. 7A). Although about
12% of these sulfonyl-resistant transformants were proved to be
wdchs2
wdchs3
double disruptants by Southern
blot analysis (Fig. 3; data shown only for
wdchs2
wdchs3
-E, lanes 4 and 10),
none exhibited reduced growth rates or abnormal phenotypes compared to
the wild type, even though all had extremely low chitin synthase
activities (Fig. 5). Other tests designed to assess the extent of the
attenuation of one of these double mutants
(wdchs2
wdchs3
-1)
showed that even in cyclophosphamide-induced
immunoincompetent (neutropenic) mice, an inoculum of these
mutant cells at least threefold higher than that of the wild type was
required in order to bring about lethal outcomes (Fig. 7B and C).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 7.
Mouse survival analyses after injection of
immunocompetent (A) and cyclophosphamide-induced immunocompromised (B
and C) mice with wild-type and wdchs mutant strains. For
each experiment with immunocompetent mice (A), groups usually numbering
10 mice were injected with log-phase yeast cells of W. dermatitidis wild type (8656),
wdchs2 -1, wdchs3 -1, wdchs2
wdchs3 -E or with
wdchs2 wdchs3 -E complemented with
either WdCHS2 (strains E2-1) or WdCHS3
(strains E3-3). The mice were injected with 9 × 106 cells per mouse and monitored for 10 to 15 days to
determine the survival rate. The data presented are in all but one case
(the triple mutant) the average data from at least two independent
experiments with each strain. Virtually identical data were obtained
for independently derived strains
wdchs2 wdchs3 -7 and
wdchs2 wdchs3 -Z and complemented
strains
wdchs2 wdchs3 -WdCHS3-E2-2 and
wdchs2 wdchs3 -WdCHS3-E3-5.
Survival fractions were calculated by the Kaplan-Meier method, and the
survival curves were tested for significant difference (P < 0.01) by the Mantel-Haenszel test by using GraphPad Prism
software, version 3.00, for Windows. The tests for virulence in the
immunocompromised mouse model were carried out with groups of mice
injected with cyclophosphamide at day 4 and at day 1 prior to fungal
infection. For each strain, groups of five mice were inoculated at four
concentrations of yeast cells, with the highest concentration being
equivalent to that usually used with W. dermatitidis in mice
with a functioning immune system, such as those used to derive the data
shown in panel A.
|
|
In order to test whether either the WdCHS2 or the
WdCHS3 gene could restore the virulence of a
wdchs2
wdchs3
mutant, putatively reconstituted strains complemented with either WdCHS2 or
WdCHS3 were constructed by directly transforming pZW9911 or
pZW9912 into the double mutant
wdchs2
wdchs3
-E,
respectively. Five sulfonyl urea-resistant transformants from each
construction were randomly chosen and assayed for chitin synthase
activities (Fig. 5; data shown only for
wdchs2
wdchs3
-WdCHS2-E2-1
and
wdchs2
wdchs3
-WdCHS3-E3-3). Of these, two of each were found to have significantly higher activities compared with that of the
wdchs2
wdchs3
-E parental strain, which indicated that the added chitin synthase activities came
from the expression of exogenous WdCHS2 or
WdCHS3. Southern blotting demonstrated that both pZW9911 and
pZW9912, the plasmids carrying these genes, respectively, were
ectopically integrated into the genomes of the two sets of strains
(Fig. 3). Tests of these strains with our immunocompetent mouse model
showed that the introduction of either gene into the double disruption
strain reestablished virulence comparable to the results seen in the wild-type strain and the wdchs2
-1 and
wdchs3
-1 single mutants (Fig. 7A).
 |
DISCUSSION |
We previously reported that single wdchs
mutants of
W. dermatitidis with either WdCHS3 or
WdCHS4 disrupted showed no loss of virulence when
tested with a mouse model of acute infection (50, 51).
This same result was also found for mutants with only WdCHS2
disrupted, as reported in this study, and for single disruption mutants
of WdCHS1 (unpublished data). Therefore, among the single
chitin synthase mutants at hand, only those with newly discovered
WdCHS5 disrupted, which lose viability with time at 37°C,
showed a loss of virulence in our acute model of infection, even though
these strains grow normally at 25°C (27). Thus, wdchs5
mutants, in the same manner as
wdchs1
wdchs2
double and wdchs1
wdchs2
wdchs3
triple
disruption mutants, presumably are rendered avirulent because their
temperature sensitivity precludes survival at temperatures of infection
(27, 50). In contrast, other tests with the same mouse
model showed that loss of virulence was very pronounced in strains
derived for this study, which had both WdCHS2 and
WdCHS3 disrupted in the same background, even though these
strains grew normally at wild-type rates and showed no morphological
abnormalities when cultured at 25 or 37°C. The extent of this
attenuation was documented further with
wdchs2
wdchs3
-1 in a more
sensitive mouse model that is being developed for W. dermatitidis, because of the increasing numbers of
phaeohyphomycosis cases that are being diagnosed among
immunocompromised patients (25, 28, 29, 52). This
surprising finding, coupled with results which showed that mutants with
both WdCHS2 and WdCHS1 disrupted are unable to
grow at 37°C but can grow weakly in an abnormal morphology at 25°C
(50, 57) and that a mutant with only WdChs2p and WdChs5p
is fully virulent, suggests that WdChs2p, unlike other class I chitin
synthases, plays a number of critically important roles in growth and
virulence because of its commonality to both processes. Although the
basis for the critical roles suggested for WdChs2p is not totally clear
at this time, we speculate that it resides in the possibility that
WdChs2p functions mainly in an auxiliary or a redundant capacity, which
compensates for the loss of function of one or more of the other chitin
synthase isozymes of W. dermatitidis.
Support for the hypothesis that WdChs2p serves in a redundant or
auxiliary capacity comes from a number of findings. The first was the
determination that WdChs2p is a class I isozyme with a number of other
attributes similar to those of its ortholog, Chs1p, in S. cerevisiae, which has become variously known as an auxiliary or
repair enzyme in that fungus. The second was the finding previously (50, 57) that the disruption of both WdCHS1 and
WdCHS2 in the same background produces strains that grow
poorly at 25°C and not at all at 37°C (50, 57). We
suggest this means that the products of these two genes are overlapping
for function at 25°C and for viability at 37°C (50,
57). A similar functionally redundant role has been suggested
recently for AnChsCp (class I) of A. nidulans, which when
disrupted together with AnChsAp (class II), causes marked hyphal and
conidial defects (18). The third was the observation that,
like Chs1p of S. cerevisiae, WdChs2p is produced in excess
of the collective activities of their counterparts and thus, in terms
of activity, could easily serve in a redundant capacity capable of
substituting for the other isozymes and particularly WdChs1p. The
fourth was our finding that mutants with only functional WdChs2p and
WdChs5p isozymes grow normally and are fully virulent, meaning that
these two enzymes together or separately are also redundant for
functions with one or more of the others. However, of these two enzymes
we know that WdChs5p cannot substitute for the loss of both WdChs1p and
WdChs2p, because the wdchs1
wdchs2
and
wdchs1
wdchs2
wdchs3
mutants
cannot survive at 37°C and thus are not rescued by any or all of
WdChs3p, WdChs4p, or WdChs5p. Taken together with the unexpected
finding presented in this report that the
wdchs2
wdchs3
mutants grew well at 37°C
but did not cause lethal infections in mice, we speculate that WdChs1p
may not function well under the many stress conditions, in addition to
temperature, which W. dermatitidis encounters during these
infections. Under this scenario, we speculate that, during infections,
either WdChs2p or WdChs3p must be present as an auxiliary chitin
synthase with the capacity to substitute for poorly functioning WdChs1p. Studies of WdChs1p and newly discovered WdChs5p are in progress to address this hypothesis.
 |
ACKNOWLEDGMENT |
This research was supported by a grant to P.J.S. from the
National Institute of Allergy and Infectious Diseases (AI 33049).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Section of
Molecular Genetics and Microbiology, University of Texas at
Austin, Austin, TX 78712. Phone: (512) 471-3384. Fax: (512) 471-7088. E-mail: pjszaniszlo{at}mail.utexas.edu.
Present address: The Institute for Genome Research, Rockville, MD 20850.
Present address: Sengenta, Research Triangle Park, NC 27709.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Aufauvre-Brown, A.,
E. Mellado,
N. A. R. Gow, and D. W. Holden.
1997.
Aspergillus fumigatus chsE: a gene related to CHS3 of S. cerevisiae and important for hyphal growth and conidiophore development but not pathogenicity.
Fungal Genet. Biol.
21:141-152[CrossRef][Medline].
|
| 2.
|
Ausubel, F. M.,
R. Bent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl.
1989.
Short protocols in molecular biology.
Wiley, New York, N.Y.
|
| 3.
|
Ballance, D. J.
1986.
Sequences important for gene expression in filamentous fungi.
Yeast
2:229-236[CrossRef][Medline].
|
| 4.
|
Beth-Din, A. B.,
C. A. Specht,
P. W. Robbins, and O. Yarden.
1996.
chs4, a class IV chitin synthase gene from Neurospora crassa.
Mol. Gen. Genet.
250:214-222[Medline].
|
| 5.
|
Bowen, A. R.,
J. L. Chen-Wu,
M. Momany,
R. Young,
P. J. Szaniszlo, and P. W. Robbins.
1992.
Classification of fungal chitin synthases.
Proc. Natl. Acad. Sci. USA
89:519-523[Abstract/Free Full Text].
|
| 6.
|
Bulawa, C. E.
1993.
Genetics and molecular biology of chitin synthesis in fungi.
Annu. Rev. Microbiol.
47:505-534[CrossRef][Medline].
|
| 7.
|
Bulawa, C. E.,
M. Slater,
E. Cabib,
J. Au-Young,
A. Sburlati,
W. L. Adair, and P. W. Robbins.
1986.
The Saccharomyces cerevisiae structural gene for chitin synthase is not required for chitin synthesis.
Cell
46:213-215[CrossRef][Medline].
|
| 8.
|
Cabib, E.,
A. Sburlati,
B. Bower, and S. J. Silverman.
1989.
Chitin synthase 1, an auxiliary enzyme for chitin synthesis in Saccharomyces cerevisiae.
J. Cell Biol.
108:1665-1672[Abstract/Free Full Text].
|
| 9.
|
Cabib, E.,
S. J. Silverman,
A. Sburlati, and M. L. Slater.
1990.
Chitin synthesis in yeast (Saccharomyces cerevisiae), p. 31-41.
In
P. J. Kuhn, A. P. J. Trinci, M. J. Jung, M. W. Goosey, and L. G. Copping (ed.), Biochemistry of cell wall and membranes in fungi. Springer-Verlag, New York, N.Y.
|
| 10.
|
Cabib, E.,
S. J. Silverman, and J. A. Shaw.
1992.
Chitinase and chitin synthase 1: counterbalancing activities in cell separation of Saccharomyces cerevisiae.
J. Gen. Microbiol.
138:97-102[Medline].
|
| 11.
|
Chen, W.
1996.
Molecular cloning and characterization of the actin gene of Wangiella dermatitidis (WdACT). M.A. thesis.
University of Texas at Austin.
|
| 12.
|
Chen-Wu, J. L.,
J. Zwicker,
A. R. Bowen, and P. W. Robbins.
1992.
Expression of chitin synthase genes during yeast and hyphal growth phases of Candida albicans.
Mol. Microbiol.
6:497-502[CrossRef][Medline].
|
| 13.
|
Cid, V.,
A. Duran,
F. D. Rey,
M. P. Snyder,
C. Nombela, and M. Sanchiez.
1995.
Molecular basis of cell integrity and morphogenesis in Saccharomyces cerevisiae.
Microbiol. Rev.
59:345-386[Abstract/Free Full Text].
|
| 14.
|
Cooper, C. R., Jr.,
J. L. Harris,
C. W. Jacobs, and P. J. Szaniszlo.
1984.
Effects of polyoxin on cellular development in Wangiella dermatitidis.
Exp. Mycol.
8:349-363.
|
| 15.
|
Cooper, C. R., Jr., and P. J. Szaniszlo.
1993.
Evidence for two cell division cycle (CDC) genes that govern yeast bud emergence in the pathogenic fungus Wangiella dermatitidis.
Infect. Immun.
61:2069-2081[Abstract/Free Full Text].
|
| 16.
|
de Hoog, G. S.,
K. Takeo,
S. Yoshida,
E. Gottlich,
K. Nishimura, and M. Miyaji.
1994.
Pleoanamorphic life cycle of Exophiala (Wangiella) dermatitidis.
Antonie Leeuwenhoek
65:143-153.
|
| 17.
|
Feng, B.,
X. Wang,
M. Hauser,
S. Kaufmann,
S. Jentsch,
G. Haase,
J. M. Becker, and P. J. Szaniszlo.
2001.
Molecular cloning and characterization of WdPKS1, a gene involved in dihydroxynaphthalene melanin biosynthesis and virulence in Wangiella (Exophiala) dermatitidis.
Infect. Immun.
69:1782-1794.
|
| 18.
|
Fujiwara, M.,
M. Ichinomiya,
T. Montoyama,
H. Horiuchi,
A. Ohta, and M. Takagi.
2000.
Evidence that the Aspergillus nidulans class I and class II chitin synthase genes, chsC and chsA, share critical roles in hyphal wall integrity and conidiophore development.
J. Biochem.
127:359-366[Abstract/Free Full Text].
|
| 19.
|
Geis, P. A., and C. W. Jacobs.
1985.
Polymorphism of Wangiella dermatitidis, p. 205-233.
In
P. J. Szaniszlo (ed.), Fungal dimorphism: with emphasis on fungi pathogenic for humans. Plenum Press, New York, N.Y.
|
| 20.
|
Gooday, G. W.
1995.
Cell walls, p. 43-62.
In
N. A. R. Gow, and G. M. Gadd (ed.), The growing fungus. Chapman and Hall, London, England.
|
| 21.
|
Gow, N. A. R.,
P. W. Robbins,
J. W. Lester,
A. J. P. Brown,
W. A. Fonzi, and O. S. Kinsman.
1994.
A hyphal specific chitin synthase gene (CHS2) is not essential for growth, dimorphism or virulence of Candida albicans.
Proc. Natl. Acad. Sci. USA
91:6216-6220[Abstract/Free Full Text].
|
| 22.
|
Harris, J. L., and P. J. Szaniszlo.
1986.
Localization of chitin in walls of Wangiella dermatitidis using colloidal gold-labeled chitinase.
Mycologia
78:853-857.
|
| 23.
|
Horiuchi, H.,
M. Fujiwara,
S. Yamashita,
A. Ohta, and M. Takagi.
1999.
Proliferation of intrahyphal hyphae caused by disruption of csmA, which encodes a class V chitin synthase with a myosin motor-like domain in Aspergillus nidulans.
J. Bacteriol.
181:3721-3729[Abstract/Free Full Text].
|
| 24.
|
Karuppayil, S. M., and P. J. Szaniszlo.
1997.
Importance of calcium to the regulation of polymorphism in Wangiella (Exophiala) dermatitidis.
J. Med. Vet. Mycol.
35:379-388[Medline].
|
| 25.
|
Kusanbach, G.,
H. Skopnik,
G. Hasse,
F. Friedrichs, and H. Dohmen.
1992.
Exophiala dermatitidis in cystic fibrosis.
Eur. J. Pediatr.
151:344-346[CrossRef][Medline].
|
| 26.
|
Kwon-Chung, K. J.,
W. E. Goldman,
B. Klein, and P. J. Szaniszlo.
1998.
Fate of transforming DNA in pathogenic fungi.
Med. Mycol.
36(Suppl. 1):38-44.
|
| 27.
|
Liu, H.,
Z. Wang,
L. Zheng,
M. Hauser,
S. Kauffman,
J. M. Becker, and P. J. Szaniszlo.
2001.
Relevance of chitin and chitin synthases to virulence in Wangiella (Exophiala) dermatitidis, a model melanized pathogen of humans, p. 463-472.
In
R. A. A. Muzzarelli (ed.), Chitin enzymology 2001. Atec Edizioni, Rome, Italy.
|
| 28.
|
Matsumoto, T.,
L. Ajello,
T. Matsuda,
P. J. Szaniszlo, and T. J. Walsh.
1994.
Developments in hyalohyphomycosis and phaeohyphomycosis.
J. Med. Vet. Mycol.
32:329-349.
|
| 29.
|
McGinnis, M. R.,
S. M. Lemon,
D. H. Walker,
G. S. de Hoog, and G. Hasse.
1999.
Fatal cerebritis caused by a new species of Cladophialophora, p. 166-171.
In
G. S. de Hoog (ed.), Studies in mycology 43. Centraalbureau voor Schimmelcultures Baarn/Delft, The Netherlands.
|
| 30.
|
McIntosh, N. D. P.
1996.
Yeast-to-hypha transition in Wangiella dermatitidis. M.A. thesis.
The University of Texas at Austin.
|
| 31.
|
Mehrad, B.,
T. A. Moore, and T. J. Standiford.
2000.
Macrophage inflammatory protein-1 alpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutopenic hosts.
J. Immunol.
165:962-968[Abstract/Free Full Text].
|
| 32.
|
Mellado, E.,
A. Aufauvre-Brown,
N. A. R. Gow, and D. W. Holden.
1996.
The Aspergillus fumigatus chsC and chsG genes encode class III chitin synthases with different functions.
Mol. Microbiol.
20:667-679[CrossRef][Medline].
|
| 33.
|
Mellado, E.,
A. Aufavre-Brown,
C. A. Specht,
P. W. Robbins, and D. W. Holden.
1995.
A multigene family related to chitin synthase genes of yeast in the opportunistic pathogen Aspergillus fumigatus.
Mol. Gen. Genet.
246:353-359[CrossRef][Medline].
|
| 34.
|
Mendoza, A. L.
1995.
Cloning and molecular characterization of the chitin synthase 1 (WdCHS1) gene of Wangiella dermatitidis. Ph.D. thesis.
The University of Texas at Austin.
|
| 35.
|
Motoyama, T.,
N. Kojima,
H. Horiuchi,
A. Ohta, and M. Takagi.
1994.
Isolation of a chitin synthase gene (chsC) of Aspergillus nidulans.
Biosci. Biotech. Biochem.
58:2254-2257[Medline].
|
| 36.
|
Munro, C. A.,
K. Winter,
A. Buchan,
K. Henry,
J. M. Becker,
A. J. P. Brown,
C. E. Bulawa, and N. A. R. Gow.
2001.
Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity.
Mol. Microbiol.
39:1414-1426[CrossRef][Medline].
|
| 37.
|
Orlean, P.
1987.
Two chitin synthases in Saccharomyces cerevisiae.
J. Biol. Chem.
262:5732-5739[Abstract/Free Full Text].
|
| 38.
|
Orlean, P.
1997.
Biogenesis of yeast wall and surface components, p. 229-362.
In
J. R. Pringle, J. R. Broach, and E. W. Jones (ed.), The molecular and cellular biology of the yeast Saccharomyces, vol. 3. Cell cycle and biology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 39.
|
Peng, M.,
C. R. Cooper, Jr., and P. J. Szaniszlo.
1995.
Genetic transformation of the pathogenic fungus Wangiella dermatitidis.
Appl. Microbiol. Biotechol.
44:444-450[CrossRef][Medline].
|
| 40.
|
Quandt, K.,
K. Frech,
K. Karas,
H. Wingender, and T. Werner.
1995.
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.
Nucleic Acids Res.
23:4878-4884[Abstract/Free Full Text].
|
| 41.
|
Roncero, C.,
M. H. Valdivieso,
J. C. Ribas, and A. Duran.
1988.
Isolation and characterization of Saccharomyces cerevisiae mutants resistant to Calcofluor white.
J. Bacteriol.
170:1950-1954[Abstract/Free Full Text].
|
| 42.
|
Sanati, H.,
C. F. Ramos,
A. S. Bayer, and M. A. Ghannoum.
1997.
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Antimicrob. Agents Chemother.
41:1345-1348[Abstract].
|
| 43.
|
Shaw, J. A.,
P. C. Mol,
B. Bowers,
S. J. Silverman,
M. H. Valdivieso,
A. Duran, and E. Cabib.
1991.
The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle.
J. Cell Biol.
114:111-123[Abstract/Free Full Text].
|
| 44.
|
Silverman, S. J.,
A. Sburlati,
M. L. Slater, and E. Cabib.
1988.
Chitin synthase 2 is essential for septum formation and cell division in Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
85:4735-4739[Abstract/Free Full Text].
|
| 45.
|
Smith, J. M.,
C. M. Tang,
S. Van Noorden, and D. W. Holden.
1994.
Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis.
Infect. Immun.
62:5247-5454[Abstract/Free Full Text].
|
| 46.
|
Specht, C. A.,
Y. Liu,
P. W. Robbins,
C. E. Bulawa,
N. Iartchouk,
K. R. Winter,
P. J. Riggle,
J. C. Rhodes,
C. L. Dodge,
D. W. Culp, and P. T. Borgia.
1996.
The chsD and chsE genes of Aspergillus nidulans and their role in chitin synthesis.
Fungal Genet. Biol.
20:153-167[CrossRef][Medline].
|
| 47.
|
Szaniszlo, P. J.,
C. W. Jacobs, and P. A. Geis.
1983.
Dimorphism: morphological and biochemical aspects, p. 323-426.
In
D. H. Howard (ed.), Fungi pathogenic for humans and animals: part A, biology. Marcel Dekker, New York, N.Y.
|
| 48.
|
Szaniszlo, P. J., and M. Momany.
1993.
Chitin, chitin synthase and chitin synthase conserved region homologues in Wangiella dermatitidis, p. 229-242.
In
B. Maresca, G. Kobayashi, and H. Yamaguchi (ed.), Molecular biology and its application to medical mycology. NATO ASI series, vol. H69. Springer-Verlag, Berlin, Germany.
|
| 49.
|
Szaniszlo, P. J.,
L. Mendoza, and S. M. Karuppayil.
1993.
Clues about chromoblastomycotic and other dematiaceous fungal pathogens based on Wangiella as a model, p. 241-255.
In
H. Vanden Bossche, F. C. Odds, and D. Kerridge (ed.), Dimorphic fungi in biology and medicine. Plenum Press, New York, N.Y.
|
| 50.
|
Wang, Z.,
L. Zheng,
M. Hauser,
J. M. Becker, and P. J. Szaniszlo.
1999.
WdChs4p, a homolog of chitin synthase 3 in Saccharomyces cerevisiae, alone cannot support growth of Wangiella (Exophiala) dermatitidis at the temperature of infection.
Infect. Immun.
67:6619-6630[Abstract/Free Full Text].
|
| 51.
|
Wang, Z., and P. J. Szaniszlo.
2000.
WdCHS3, a gene that encodes a class III chitin synthase in Wangiella (Exophiala) dermatitidis, is expressed differentially under stress conditions.
J. Bacteriol.
182:874-881[Abstract/Free Full Text].
|
| 52.
|
Xu, X.,
D. W. Low,
H. I. Palevsky, and R. Elentitsas.
2001.
Subcutaneous cysts caused by Exophiala jeanselmei in a lung transplant patient.
Dermatol. Surg.
27:343-346[CrossRef][Medline].
|
| 53.
|
Yanai, K.,
N. Kojima,
N. Takaya,
H. Horiuchi,
A. Ohta, and M. Takagi.
1994.
Isolation and characterization of two chitin synthase genes from Aspergillus nidulans.
Biosci. Biotechnol. Biochem.
58:1828-1835[Medline].
|
| 54.
|
Yarden, O., and C. Yanofsky.
1991.
Chitin synthase 1 plays a major role in cell wall biogenesis in Neurospora crassa.
Genes Dev.
5:2420-2430[Abstract/Free Full Text].
|
| 55.
|
Ye, X.,
B. Feng, and P. J. Szaniszlo.
1999.
A color-selectable and site-specific integrative transformation system for gene expression studies in the dematiaceous fungus Wangiella (Exophiala) dermatitidis.
Curr. Genet.
36:241-247[CrossRef][Medline].
|
| 56.
|
Ye, X., and P. J. Szaniszlo.
2000.
Expression of a constitutively active Cdc42 homologue promotes development of sclerotic bodies but represses hyphal growth in the zoopathogenic fungus Wangiella (Exophiala) dermatitidis.
J. Bacteriol.
182:4941-4950[Abstract/Free Full Text].
|
| 57.
|
Zheng, L.
1997.
Establishment of genetic transformation systems in and molecular cloning of the chitin synthase 2 (WdCHS2) gene, and characterization of the WdCHS1 and WdCHS2 genes of Wangiella dermatitidis. Ph.D. thesis.
The University of Texas at Austin.
|
| 58.
|
Zheng, L., and P. J. Szaniszlo.
1999.
Cloning and use of the WdURA5 gene as a hisG cassette selection marker for potentially disrupting multiple genes in Wangiella dermatitidis.
Med. Mycol.
37:85-96[CrossRef][Medline].
|
Infection and Immunity, December 2001, p. 7517-7526, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7517-7526.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Weber, I., Assmann, D., Thines, E., Steinberg, G.
(2006). Polar Localizing Class V Myosin Chitin Synthases Are Essential during Early Plant Infection in the Plant Pathogenic Fungus Ustilago maydis. Plant Cell
18: 225-242
[Abstract]
[Full Text]
-
Liu, H., Kauffman, S., Becker, J. M., Szaniszlo, P. J.
(2004). Wangiella (Exophiala) dermatitidis WdChs5p, a Class V Chitin Synthase, Is Essential for Sustained Cell Growth at Temperature of Infection. Eukaryot Cell
3: 40-51
[Abstract]
[Full Text]
-
Wang, Q., Liu, H., Szaniszlo, P. J.
(2002). Compensatory expression of five chitin synthase genes, a response to stress stimuli, in Wangiella (Exophiala) dermatitidis, a melanized fungal pathogen of humans. Microbiology
148: 2811-2817
[Abstract]
[Full Text]
| This Article |
 |
![Right arrow]() | |